Medical Retina Fellowship
$174,930ZIEFY2013EYNIH
National Eye Institute
Investigators
Linked publications & trials
Paper 25109928Paper 25077529Paper 24974817Paper 24614146Paper 24613825Paper 24526414Paper 23887802Paper 23713713Paper 23689994Paper 23645227Paper 23620429Paper 23582353Paper 23548622Paper 23064429Paper 22906772Paper 22589436Paper 22266930Paper 21684602Paper 21567211Paper 21273946Paper 20926818Paper 20574018Paper 20375333Paper 20337261Paper 20216418Paper 20079925Paper 20065216Paper 20038863Paper 20007836Paper 19996825Paper 19952996Paper 19878127Paper 19700198Paper 19696804Paper 19628747Paper 19573860Paper 19516114Paper 19434233Paper 19139352Paper 19091420Paper 18854947Paper 18789534Paper 18779490Paper 18718667
Abstract
A number of medical retinal protocols have been conducted at the NEI clinical center. Many are phase 1 studies while others are studies in the screening and evaluation and treatment protocol. These provide patients for screening for trials and epidemiologic studies conducted by the Division of Epidemiology and Clinical Applications. . These include the followup of Age-Related Eye Disease Study, lucentis (anti-VEGF therapy) with high speed indocyanine green angiography for age-related macular degeneration, treatment with microglial inhibitors for diabetic retinopathy and retinovascular occlusions, treatments for central serous retinopathy, and genetic studies of age-related macular degeneration.
View original record on NIH RePORTER →